Wells Fargo analyst Ike Boruchow lowered the firm’s price target on Bath & Body Works to $40 from $48 and keeps an Equal Weight rating on the shares. The firm is cautious into Q2 EPS, and is lowering its Q2 estimates and cutting second half of the year numbers. The story continues to struggle finding a bottom, and following weak checks throughout Q2, Wells expects things will get worse before they get better.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- TJX price target raised to $122 from $113 at Morgan Stanley
- Bath & Body Works call volume above normal and directionally bullish
- Bath & Body Works price target lowered to $39 from $47 at Piper Sandler
- Bath & Body Works director Nash sells 48,000 common shares
- Bath & Body Works collaborates with Accenture